Darwin Global Management, Ltd.
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationst. helier, Y9
- CIK0001839209
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
6 | $1.06B | INSM, JAZZ PHARMACEUTICALS PLC, VRNA, GON | 13F-HR | Feb 14, 2025 | 000189268825000094 | ||
5 | $1.23B | INSM, PCVX, GON, KROS | 13F-HR | Nov 14, 2024 | 000189268824000146 | ||
9 | $859.47M | CYTK, INSM, PCVX, GON | 13F-HR | Aug 14, 2024 | 000189268824000095 | ||
12 | $751.17M | PCVX, NUVL, KROS, BIOHAVEN LTD | 13F-HR | May 15, 2024 | 000189268824000066 | ||
8 | $509.48M | AMAM, TG THERAPEUTICS INC, MLTX, CYTK | 13F-HR | Feb 14, 2024 | 000189268824000038 | ||
3 | $284.15M | AMAM, IMVT, ARGX | 13F-HR | Nov 14, 2023 | 000189268823000097 | ||
3 | $611.70M | AMAM, TG THERAPEUTICS INC, ARGX | 13F-HR | Aug 14, 2023 | 000189268823000068 | ||
4 | $365.62M | TG THERAPEUTICS INC, ARGX, AMAM, KROS | 13F-HR | May 15, 2023 | 000189268823000053 | ||
4 | $160.63M | ARGX, KROS, AMAM, RXDX | 13F-HR | Feb 14, 2023 | 000189268823000024 | ||
2 | $66.41M | VTYX, KRTX | 13F-HR | Nov 14, 2022 | 000142050622002329 | ||
1 | $188.24M | AZN | 13F-HR | Aug 15, 2022 | 000142050622001745 | ||
1 | $110.24M | AZN | 13F-HR | May 16, 2022 | 000142050622001096 | ||
13 | $654.59M | PFE, NTLA, AZN, 2450449D | 13F-HR | Feb 14, 2022 | 000142050622000465 | ||
12 | $543.28M | ACCELERON PHARMA INC, NTLA, BNTX, FATE | 13F-HR | Nov 15, 2021 | 000142050621001717 | ||
12 | $619.93M | NTLA, ACCELERON PHARMA INC, FATE, BBIO | 13F-HR | Aug 16, 2021 | 000142050621001288 | ||
12 | $510.68M | ACCELERON PHARMA INC, BBIO, FATE, RLAY | 13F-HR | May 17, 2021 | 000142050621000787 | ||
12 | $358.39M | ACCELERON PHARMA INC, FATE, MYG, BBIO | 13F-HR | Feb 16, 2021 | 000142050621000329 |